"Opponents are taking advantage of the well-intentioned but vague language in the Convention on Biological Diversity and the associated Cartagena Protocol to stimulate the imposition of regulations that make progress almost impossible," Strauss said. "They treat a small-scale research plot the same as use of a genetically-modified tree over an entire region."
And while earlier kinds of genetically modified trees almost exclusively contained genes from other species, many current advances are being made with native genes and natural growth processes, which are increasing as genomic science advances. No distinction is being allowed for that type of science, the researchers said.
The researchers said they believe that the convention has become a "platform for imposing broad restrictions on research and development of all types of transgenic trees regardless of their ecological and economic benefits."
This convention is one of the largest international treaties, first developed in 1992, and was initially designed to protect biodiversity, not preclude use of genetically modified organisms.
"The activism against genetically modified trees through the Convention on Biological Diversity has been against all forms of genetic modification, regardless of the goals or environmental benefits sought," the researchers wrote in their report. "This activism has also been in direct opposition to widespread scientific and professional opinion from around the world, including from ecologists, that the trait, not the recombinant method, should be the focus of assessments."
Another key part of the problem, the researchers said, is finding enough scientists to partic
'/>"/>
| Contact: Steven Strauss steve.strauss@oregonstate.edu 541-760-7357 Oregon State University Source:Eurekalert |